510(k) Report

510(k) · Cleared

Cleared

Depuy Ceramic Femoral Heads

K031803510(k) SpecialCleared Jul 1, 200320-day reviewClass II21 CFR 888.3353

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

DePuy Orthopaedics, Inc. · LZO Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented

Cleared on Jul 1, 2003 as substantially equivalent to K011533 (DePuy Orthopaedics, Inc., 2002) after a 20-day review. Its family tree reaches back 1 generation to 2002. 377 later devices descend from it.

Decided
Jul 1, 2003
Review
20 days
Class
Class II
Product code
LZO
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K011533 (2002). 377 later devices descend from it, 9 citing it directly.

Descendants, by year cleared 2004: 1 descendant cleared2015: 17 descendants cleared2007: 3 descendants cleared2023: 22 descendants cleared2005: 3 descendants cleared2006: 4 descendants cleared2024: 29 descendants cleared2016: 16 descendants cleared2009: 6 descendants cleared2011: 13 descendants cleared2013: 20 descendants cleared2008: 6 descendants cleared2012: 17 descendants cleared2018: 21 descendants cleared2014: 17 descendants cleared2025: 30 descendants cleared2019: 33 descendants cleared2017: 15 descendants cleared2010: 5 descendants cleared2021: 21 descendants cleared2020: 26 descendants cleared2022: 25 descendants cleared2026: 27 descendants clearedK011533 · Depuy Femoral Heads · DePuy Orthopaedics, Inc. · 2002200020052010201520202025
Descendants, by generation 1 generation forward: 9 descendants2 generations forward: 23 descendants3 generations forward: 44 descendants4 generations forward: 72 descendants5 generations forward: 71 descendants6 generations forward: 71 descendants7 generations forward: 54 descendants8 generations forward: 29 descendants9 generations forward: 3 descendants10 generations forward: 1 descendant K011533 · Depuy Femoral Heads · DePuy Orthopaedics, Inc. · 20020+5+10
  1. Root · 1 generation backK011533 Depuy Femoral HeadsDePuy Orthopaedics, Inc. · 2002
  2. This deviceK031803 Depuy Ceramic Femoral HeadsDePuy Orthopaedics, Inc. · 2003
  3. Descendant · cites it directly · 345 of its ownK042091 Biolox Delta Ceramic HeadsBiomet, Inc. · 2005 · Recalled
  4. Descendant · 2 generations on · 344 of its ownK051411 Arcomxl Polyethylene Liners and Biolox Delta HeadsBiomet, Inc. · 2005 · Recalled
  5. Descendant · 2 generations on · 343 of its ownK061312 36MM Biolox Delta Ceramic HeadsBiomet, Inc. · 2006
  6. Descendant · cites it directly · 222 of its ownK040644 Modification to Depuy Ceramic Femoral HeadDePuy Orthopaedics, Inc. · 2004
  7. Descendant · cites it directly · 219 of its ownK062748 Modification: to Depuy Delta Ceramic Femoral HeadDePuy Orthopaedics, Inc. · 2006

Showing 5 of 377 descendants. See all descendants

Descendants cleared per year

2004: 12005: 32006: 42007: 32008: 62009: 62010: 52011: 132012: 172013: 202014: 172015: 172016: 162017: 152018: 212019: 332020: 262021: 212022: 252023: 222024: 292025: 302026: 27
2004high 33 (2019) · low 1 (2004)2026

Most influential descendants

Showing 5 of 377 · See all
  • K042091Biolox Delta Ceramic HeadsBiomet, Inc. · 2005 · cites it directly345descendants
  • K051411Arcomxl Polyethylene Liners and Biolox Delta HeadsBiomet, Inc. · 2005 · 2 generations on344descendants
  • K06131236MM Biolox Delta Ceramic HeadsBiomet, Inc. · 2006 · 2 generations on343descendants
  • K040644Modification to Depuy Ceramic Femoral HeadDePuy Orthopaedics, Inc. · 2004 · cites it directly222descendants
  • K062748Modification: to Depuy Delta Ceramic Femoral HeadDePuy Orthopaedics, Inc. · 2006 · cites it directly219descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K011533Depuy Femoral HeadsDePuy Orthopaedics, Inc.2002—
0 (this device)K031803Depuy Ceramic Femoral HeadsDePuy Orthopaedics, Inc.2003—
+1K042091Biolox Delta Ceramic HeadsBiomet, Inc.20052
+2K051411Arcomxl Polyethylene Liners and Biolox Delta HeadsBiomet, Inc.20051
+2K06131236MM Biolox Delta Ceramic HeadsBiomet, Inc.2006—
+1K040644Modification to Depuy Ceramic Femoral HeadDePuy Orthopaedics, Inc.2004—
+1K062748Modification: to Depuy Delta Ceramic Femoral HeadDePuy Orthopaedics, Inc.2006—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200410
200530
200640
200730
200860
200960
201050
2011130
2012170
2013200
2014170
2015170
2016160
2017150
2018210
2019330
2020260
2021210
2022250
2023220
2024290
2025300
2026270
FIG. 1 — Lineage of K031803, 2002–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LZO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LZO device

  1. #1 K192827 Quadra-Pscore 19.3 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K011533Depuy Femoral HeadsDePuy Orthopaedics, Inc.2002—

Also cleared against K011533: 3 other devices →

What descends from it? (377)

See all 377

9 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K042091Biolox Delta Ceramic HeadsBiomet, Inc.2005345
K040644Modification to Depuy Ceramic Femoral HeadDePuy Orthopaedics, Inc.2004222
K062748Modification: to Depuy Delta Ceramic Femoral HeadDePuy Orthopaedics, Inc.2006219
K060918Excia Total Hip System 12/14 Trunnion with Ceramic HeadAesculap, Inc.200690
K041940Howmedica Osteonics Zirconia-Toughened-Alumina (Biolox Delta) Ceramic Femoral HeadsHowmedica Osteonics Corp.200518
K071830Depuy Delta TS Ceramic Femoral HeadsDePuy Orthopaedics, Inc.200714
K222296ARTICUL/EZE Ceramic HeadsDepuy Ireland UC20236
K231873DePuy SUMMIT Porocoat Hip Prosthesis – MR Conditional, DePuy SUMMIT DuoFix Hip…Depuy Ireland UC20245
K150576TGM Biolox delta Ceramic HeadsTgm Medical, Inc.20150

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K042091 (Biomet, Inc., 2005) has gone furthest, with 345 descendants of its own.
  • 3 other devices also cite its predicate K011533.

How does its category compare?

All LZO devices

LZO Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LZO

14in 2025

2007: 92008: 112009: 72010: 152011: 132012: 142013: 262014: 132015: 122016: 102017: 162018: 182019: 282020: 182021: 122022: 112023: 102024: 112025: 142026 (partial year): 9
2007high 28 (2019) · low 7 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LZO

119in 2025

2007: 87 days median2008: 63 days median2009: 83 days median2010: 78 days median2011: 87 days median2012: 98 days median2013: 100 days median2014: 85 days median2015: 115 days median2016: 177 days median2017: 257 days median2018: 163 days median2019: 109 days median2020: 112 days median2021: 170 days median2022: 279 days median2023: 122 days median2024: 111 days median2025: 119 days median2026 (partial year): 102 days median
2007high 279 (2022) · low 63 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LZO

1in 2025

2007: 22008: 132009: 422011: 102012: 142014: 12015: 12016: 92017: 52018: 22019: 42020: 32022: 42023: 22024: 12025: 1
2007high 42 (2009) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LZO

3,244in 2025

2007: 1382008: 1252009: 1892010: 3942011: 5442012: 9632013: 1,3702014: 1,4772015: 1,3482016: 1,7282017: 2,1652018: 3,1332019: 3,0662020: 1,9632021: 2,1992022: 1,9852023: 2,0662024: 2,5862025: 3,244
2007high 3,244 (2025) · low 125 (2008)2025

MAUDE reports naming product code LZO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20079872138
2008116313125
200978342189
201015780394
2011138710544
2012149814963
20132610001,370
2014138511,477
20151211511,348
20161017791,728
20171625752,165
20181816323,133
20192810943,066
20201811231,963
20211217002,199
20221127941,985
20231012222,066
20241111112,586
20251411913,244
202691020—

What is it indicated for?

The DePuy Ceramic Femoral Heads are indicated for use as the femoral head component in total hip arthroplasty procedures. Total hip arthroplasty is intended to provide increased patient mobility and reduce pain by replacing the damaged hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. Total hip replacement is indicated in the following conditions: 1. A severely painful and/or disabled…

Read the full statement (122 words)

The DePuy Ceramic Femoral Heads are indicated for use as the femoral head component in total hip arthroplasty procedures.

Total hip arthroplasty is intended to provide increased patient mobility and reduce pain by replacing the damaged hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. Total hip replacement is indicated in the following conditions:

1. A severely painful and/or disabled joint from osteoarthritis, traumatic artlmtis, rheumatoid arthritis, or congenital hip dysplasia.

2. Avascular necrosis of the femoral head.

3. Acute traumatic hcture of the femoral head or neck.

4. Failed previous hip surgery including joint reconstruction, internal fixation, arthrodesis, hemiarthroplasty, surface replacement arthroplasty, or total hip replacement.

5. Certain cases of ankylosis.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K031803: Depuy Ceramic Femoral Heads.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K031803

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026